Annovis Bio Inc ANVS:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:10 PM EDT
23.50quote price arrow up+0.22 (+0.95%)
Volume
3,464
Close
23.28quote price arrow down-1.71 (-6.84%)
Volume
176,272
52 week range
3.36 - 47.99

...

Loading . . .
  • Open29.44
  • Day High29.44
  • Day Low22.83
  • Prev Close24.99
  • 52 Week High47.99
  • 52 Week High Date03/16/21
  • 52 Week Low3.36
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap161.80M
  • Shares Out6.95M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change208.75

KEY STATS

  • Open29.44
  • Day High29.44
  • Day Low22.83
  • Prev Close24.99
  • 52 Week High47.99
  • 52 Week High Date03/16/21
  • 52 Week Low3.36
  • 52 Week Low Date05/14/20
  • Market Cap161.80M
  • Shares Out6.95M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change208.75

RATIOS/PROFITABILITY

  • EPS (TTM)-1.19
  • P/E (TTM)-19.52
  • Fwd P/E (NTM)-145.50
  • EBITDA (MRQ)-9.286M
  • ROE (MRQ)-109.16%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/21/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Annovis Bio Inc

There is no recent news for this security.

Profile

MORE
Annovis Bio, Inc. is a clinical stage, drug platform company. The Company is focused on addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD). The Company is engaged in developing drugs that normalize the transport of information within and between nerve cells, called axonal transport. Its lead product pipelines are ANVS-401, which include ANVS-401 for AD, ANVS-401 for AD-DS, ANVS-401 for PD;...
Michael Hoffman
Chairman
Address
1055 Westlakes Dr Ste 300
Berwyn, PA
19312-2410
United States